COVID-19 vaccination in Argentina

Last updated
COVID-19 vaccination campaign in Argentina
Date29 December 2020 (2020-12-29) – present
Location Argentina
Cause COVID-19 pandemic in Argentina
TargetImmunisation of Argentines against COVID-19

The COVID-19 vaccination program in Argentina is an ongoing effort of mass immunization. Vaccination against COVID-19 began in Argentina on 29 December 2020 aiming at health professionals. Argentina struck a deal with the United Kingdom in November 2020 for a British made vaccine produced by the pharmaceutical company AstraZeneca and the University of Oxford. The vaccines are part of a deal where Argentina received 22.4 million doses. [1] During the first week, 39,599 doses were applied to health professionals. [2]

Contents

On 18 February 2021, vaccination on citizens aged over 70 began in the Province of Buenos Aires. Schools, among other sites, were used as temporary vaccination centres. [3]

Background

President of Argentina Alberto Fernandez receiving the Sputnik V vaccine on 21 January 2021. Alberto Fernandez recibio la primera dosis de la vacuna Sputnik V.jpg
President of Argentina Alberto Fernández receiving the Sputnik V vaccine on 21 January 2021.

During the first days of November, the government announced that will acquire during December 2020 and January 2021, 25 million of doses from the Russian vaccine Sputnik V after it would enter phase III. [4] [5] [6] Other vaccines such as the developed by University of Oxford and AstraZeneca, Pfizer, and China were also announced to be acquired eventually. [7]

On 22 December the flight that would bring the first doses of the Sputnik V vaccine to the country left for Moscow, [8] after negotiations began in early December. [9] 300,000 doses arrived on 24 December, [10] with the vaccination campaign beginning on 29 December. [11] The governor of the province of Buenos Aires, Axel Kicillof, was among the first to receive the vaccine. [12] One day later, the AZD1222 vaccine developed by University of Oxford and AstraZeneca was also approved in the country. [13]

On 29 May 2021, health minister Carla Vizzotti met with Cuban president Miguel Díaz-Canel to discuss the possibility of distribution of the still unapproved Cuban-made vaccine SOBERANA 02. [14] [15]

On July 17, 2021, 3.5 million doses of Moderna vaccines arrived at Argentina as part of donation from the United States. [16] Before that, on July 9, 2021, Argentina announced that it had procured 20 million doses from Moderna on its supply deal. [17]

Vaccines on order

VaccineApprovalDeployment
Pfizer–BioNTech Green check.svg YesGreen check.svg Yes
Oxford–AstraZeneca Green check.svg YesGreen check.svg Yes
Sputnik V Green check.svg YesGreen check.svg Yes
Sinopharm BIBP Green check.svg YesGreen check.svg Yes
Moderna Green check.svg YesGreen check.svg Yes
Bharat Biotech Green check.svg YesDark Red x.svg No
CanSino Green check.svg Yes [18] Dark Red x.svg No

Vaccines in trial stage

VaccineType (technology)Phase IPhase IIPhase III
CureVac RNAGreen check.svg CompletedGreen check.svg CompletedIn progress
ReiThera Viral vectorGreen check.svg CompletedGreen check.svg CompletedIn progress

Related Research Articles

COVID-19 pandemic in Argentina Ongoing COVID-19 viral pandemic in Argentina

The COVID-19 pandemic in Argentina is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. On 3 March 2020, the virus was confirmed to have spread to Argentina. As of 21 November 2021, a total of 5,314,702 people were confirmed to have been infected, and 116,374 people were known to have died because of the virus. On 7 March 2020, the Ministry of Health confirmed the country's first documented death, a 64-year-old man who had travelled to Paris, France, who also had other health conditions; the case was only confirmed as positive after the patient's demise.

Sputnik V COVID-19 vaccine Vaccine against COVID-19

Sputnik V or Gam-COVID-Vac is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world's first registered combination vector vaccine for the prevention of COVID-19, having been registered on 11 August 2020 by the Russian Ministry of Health.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Carla Vizzotti Argentine public official

Carla Vizzotti is an Argentine physician specialized in vaccine-preventable diseases. She was the Secretary of Health Access and Vice Minister of Health in Argentina's Health Ministry, working under Minister Ginés González García, until February 2021. She has been Minister of Health since 20 February 2021, following González García's resignation.

COVID-19 vaccination in Italy Immunization plan against COVID-19 in Italy

The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.

European Commission–AstraZeneca COVID-19 vaccine dispute Dispute between the European Union and AstraZeneca

A dispute broke out in January 2021 between the European Commission and the pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute over Article 16 of the Northern Ireland Protocol. Vaccination proceeded apace in the UK but more slowly in the EU, and by the end of March 2021, over 30% of the UK population had received at least one dose of vaccine compared to about 8% of the EU population. This was partly due to limited availability of the AstraZeneca vaccine in the EU. The World Health Organization and the European Medicines Agency continued to state that the vaccine was safe and effective. However, a representative of the European Medicines Agency said in June that vaccines based on the mRNA technology should be preferred if available for all age groups, including for the over 60s.

COVID-19 vaccination in Peru

The COVID-19 vaccination program in Peru is the national vaccination strategy to protect the population against SARS-CoV-2 employing vaccines developed for the COVID-19 pandemic in Peru. Vaccination began on 9 February 2021, after three days of arrival of first vaccines. On a nation message, the head of state Francisco Sagasti confirmed the purchase of 38 millions of vaccines, being one million of vaccines for health personnel.

The Argentine COVID-19 vaccination scandal, known in Argentina as vacunatorio VIP, is a political scandal related to the application of COVID-19 vaccines in the Ministry of Health of Argentina to citizens who, due to the limitations established in the vaccination protocol, were not authorized to receive these vaccines yet.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The COVID-19 virus was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Vietnam Plan to immunize against COVID-19 in Vietnam

The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in South Korea Plan to immunize against COVID-19

COVID-19 vaccination in South Korea is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Indonesia

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks fifth in the world and second in Asia.

COVID-19 vaccination in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

Sputnik Light Vaccine against COVID-19

Sputnik Light is a single dose COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector, and it can be stored at a normal refrigerator temperature of 2–8 °C (36–46 °F). The institute says this version would be ideally suited for areas with acute outbreaks, allowing more people to be vaccinated quickly. It will also be used as a third (booster) dose for those who received Sputnik V at least 6 months earlier.

COVID-19 vaccination in Sri Lanka Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Taiwan Plan to immunize against COVID-19

COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021.

References

  1. "Covid-19 vaccinations begin in provinces across country". Buenos Aires Times (Perfil). 29 December 2020.
  2. "Ya se aplicaron 39.599 dosis de la vacuna contra COVID-19 al personal de salud" [39,599 doses of the vaccine against COVID-19 were applied to health professionals] (in Spanish). Ministry of Health. 6 January 2021.
  3. "Buenos Aires Province begins vaccinating those aged 70+". Buenos Aires Times (Perfil). 18 February 2021.
  4. Boadle, Anthony; Raszewski, Eliana; Garrison, Cassandra (2 November 2020). "Argentina expects 10 million doses of Russian COVID-19 vaccine". Reuters. Retrieved 6 November 2020.
  5. "Argentina agrees to buy 25 million doses of Russia's Covid-19 vaccine". Buenos Aires Times (Perfil). 3 November 2020. Retrieved 6 November 2020.
  6. "Salud confirmó que adquirirá 25 millones de dosis de la vacuna rusa si pasa la fase 3" (in Spanish). Télam. 4 November 2020. Retrieved 5 November 2020.
  7. Heath, Maximilian (6 November 2020). "Argentina 'could receive' 750,000 doses of eventual Pfizer vaccine: Fernandez". Reuters. Retrieved 7 November 2020.
  8. "Parte hacia Moscú el vuelo que traerá al país las primeras dosis de la Sputnik V" (in Spanish). Télam. 22 December 2020.
  9. "Government inks deal for 10 million doses of Russia's Covid-19 vaccine". Buenos Aires Times (Perfil). 12 December 2020.
  10. Otaola, Jorge; Sherwood, Dave (26 December 2020). "Argentina to launch COVID-19 vaccination campaign on Tuesday". Reuters.
  11. Misculin, Nicolás; Sherwood, Dave (29 December 2020). "Argentina begins COVID vaccination drive with Russia's Sputnik V". Reuters.
  12. "Kicillof among first to receive Russian vaccine in Argentina". Buenos Aires Times (Perfil). 29 December 2020.
  13. "Argentina approves AstraZeneca-Oxford Covid vaccine". Buenos Aires Times (Perfil). 30 December 2020.
  14. "Vacunas cubanas: Díaz-Canel recibió a Carla Vizzotti" [Cuban vaccines: Díaz-Canel received Carla Vizzotti]. Página 12 (in Spanish). 29 May 2021. Retrieved 30 May 2021.
  15. "Carla Vizzotti se reunió en Cuba con el presidente Díaz-Canel" [Carla Vizzotti met in Cuba with President Díaz-Canel]. La Voz (in Spanish). Télam. 29 May 2021. Retrieved 30 May 2021.
  16. "United States donates 3.5 million Moderna vaccines to Argentina". Buenos Aires Times . July 17, 2021. Retrieved August 3, 2021.
  17. "Argentina announces COVID-19 vaccine supply deal with Moderna". Reuters . July 9, 2021. Retrieved August 3, 2021.
  18. "Argentina issues emergency approval to China's single-dose Cansino COVID-19 vaccine". Reuters. 2021-06-11. Retrieved 2021-06-11.